V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240008672 | 240010921 | 1.57 | 71.7 | Palliative (P) | null | 2018-01-22 | ABVD | null | N | 240019983 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINBLASTINE |
| 240008673 | 240010921 | 1.63 | 53.3 | Disease modification (D) | null | 2013-09-15 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | N | N | 240019983 | BEVACIZUMAB + CARBO + DOCETAXEL |
| 240008674 | 240005291 | 1.51 | null | Curative (C) | 2016-07-26 | 2016-12-05 | RUXOLITINIB | N | N | 240020046 | CYTARABINE HD + METHOTREXATE HD |
| 240008675 | 240005292 | 1.64 | 0 | Curative (C) | 2013-11-29 | 2013-11-30 | Cisplatin + Topotecan | N | N | 240020088 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 240008676 | 240005293 | 2.04 | 94.75 | Adjuvant (A) | 2017-01-31 | 2017-01-31 | ECX | 2 | N | 240020112 | ABVD |
| 240008677 | 240010922 | 1.72 | 68.7 | Palliative (P) | 2017-01-05 | 2017-01-12 | Cisplatin + Etoposide (3 day) | N | N | 240020174 | BEACOPP |
| 240008678 | 240005294 | 1.6 | 62.5 | Palliative (P) | 2018-07-29 | 2018-07-29 | Bevacizumab 15mg/kg | 02 | N | 240020241 | METHOTREXATE |
| 240008679 | 240005295 | 1.74 | 94.8 | Palliative (P) | 2016-04-30 | 2016-05-05 | Methotrexate intrathecal | N | N | 240020250 | CHLORAMBUCIL + OBINUTUZUMAB |
| 240008680 | 240005296 | 1.57 | 67.8 | Curative (C) | 2014-09-19 | 2014-09-19 | CHOEP - 21 days | 02 | N | 240020261 | CHOP R + METHOTREXATE |
| 240008681 | 240005297 | 1.81 | 83.7 | Curative (C) | 2017-11-10 | 2017-11-10 | VEDex | N | N | 240020299 | AML19 TRIAL |
| 240008682 | 240005298 | null | 65.2 | Curative (C) | 2016-12-09 | 2016-12-22 | Cisplatin + Topotecan | 99 | N | 240020325 | FEC + DOCETAXEL |
| 240008683 | 240005299 | 1.52 | 0 | Palliative (P) | 2017-10-05 | 2017-10-17 | VAC | N | N | 240020361 | MITOXANTRONE |
| 240008684 | 240005300 | 1.64 | 83 | Palliative (P) | 2018-02-13 | 2018-02-15 | VINCRISTINE | 02 | N | 240020368 | CHOEP |
| 240008685 | 240005301 | 1.54 | 76 | null | 2015-01-08 | 2015-01-15 | CAPECITABINE + RT | N | N | 240020386 | CISPLATIN + ETOPOSIDE |
| 240008686 | 240010923 | 0 | 98 | Disease modification (D) | 2018-04-03 | 2018-04-12 | NORDIC | 02 | N | 240020387 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 240008687 | 240005302 | 1.79 | 0 | Curative (C) | 2013-11-20 | 2013-11-21 | ABVD | N | N | 240020476 | R-EPOCH |
| 240008688 | 240005303 | 1.57 | null | null | 2013-06-21 | 2013-06-30 | IVA | N | N | 240020509 | FCR |
| 240008689 | 240010924 | 1.65 | 79 | null | 2017-06-19 | 2017-07-10 | Paclitaxel 7 day | N | N | 240020535 | CLADRIBINE |
| 240008690 | 240005304 | 0 | 71 | Curative (C) | 2018-02-19 | 2018-02-22 | R-EPOCH | N | N | 240020602 | CHOEP |
| 240008691 | 240005305 | 1.68 | 66.7 | Not known (9) | 2016-03-09 | 2016-03-15 | CISPLATIN + MITOMYCIN | N | N | 240020605 | CYTARABINE |
| 240008692 | 240005306 | 1.65 | 89 | Palliative (P) | null | 2017-10-05 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 1 | null | 240020607 | METHOTREXATE INTRATHECAL |
| 240008693 | 240005307 | 0 | null | Palliative (P) | 2018-06-09 | 2018-06-11 | CARBOPLATIN + GEMCITABINE | N | N | 240020637 | CISPLATIN + VINORELBINE |
| 240008694 | 240005308 | 1.65 | null | Curative (C) | 2019-02-04 | 2019-02-04 | NHL 2003 Gp B COP | N | null | 240020675 | GEMCARBO |
| 240008695 | 240010925 | 1.6 | 62 | Disease modification (D) | 2018-05-21 | 2018-05-31 | IVA | N | N | 240020689 | CISPLATIN + ETOPOSIDE |
| 240008696 | 240013642 | 1.9 | 75 | Curative (C) | 2017-10-03 | 2017-10-03 | Methotrexate intrathecal | 02 | N | 240020694 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 240008697 | 240013642 | 1.65 | 53.7 | Palliative (P) | 2017-11-10 | 2017-11-17 | LENALIDOMIDE | N | N | 240020694 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 240008698 | 240005309 | 1.52 | 0 | Palliative (P) | 2013-11-02 | 2013-11-04 | GEMCARBO | N | N | 240020709 | IBRUTINIB |
| 240008699 | 240005309 | 1.6 | 60.7 | Curative (C) | 2015-09-26 | 2015-09-28 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | N | N | 240020709 | CYCLO + RITUXIMAB + VINCRISTINE |
| 240008700 | 240005310 | 1.68 | 67.7 | Curative (C) | 2019-05-28 | 2019-06-02 | BLEOMYCIN + CYCLOPHOSPHAMIDE + ETOPOSIDE + MITOXANTRONE + RITUXIMAB + VINCRISTINE | N | N | 240020743 | BEAM |
| 240008701 | 240005311 | 1.85 | 77 | Palliative (P) | 2017-09-17 | 2017-09-18 | GEMCARBO | 02 | N | 240020761 | R-EPOCH |
| 240008702 | 240005312 | 1.77 | null | Palliative (P) | 2015-08-03 | 2015-08-03 | Cyclophosphamide + Dex + Rituximab | 2 | N | 240020774 | FLUDARABINE |
| 240008703 | 240005313 | 1.58 | 49.4 | Adjuvant (A) | 2016-04-14 | 2016-04-21 | CAPECITABINE + RT | 2 | N | 240020798 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 240008704 | 240005314 | 1.75 | 73.3 | Curative (C) | 2015-06-23 | 2015-07-10 | Cyclophosphamide TBI Allograft | 02 | N | 240020856 | BORTEZOMIB |
| 240008705 | 240005314 | 1.88 | 76.9 | Palliative (P) | 2016-05-27 | 2016-05-29 | CHOEP | Y | N | 240020856 | IBRUTINIB |
| 240008706 | 240005315 | 1.68 | 82.8 | Curative (C) | 2017-08-19 | 2017-08-30 | Cyclophosphamide + Dex + Rituximab | N | N | 240020907 | TAC |
| 240008707 | 240005316 | null | 71 | Curative (C) | 2017-05-23 | 2017-06-03 | Cytarabine Low Dose | N | N | 240020924 | FCR |
| 240008708 | 240005317 | 1.62 | 105 | Palliative (P) | 2014-03-17 | 2014-03-22 | PCV | 02 | N | 240021024 | VINBLASTINE |
| 240008709 | 240005318 | 1.73 | null | Palliative (P) | 2016-11-12 | 2016-11-27 | AML17 TRIAL | N | N | 240021060 | GEMCITABINE |
| 240008710 | 240005318 | 1.73 | 72 | Adjuvant (A) | 2017-01-08 | 2017-01-16 | Cyclophosphamide + Dex + Rituximab | N | N | 240021060 | NORDIC |
| 240008711 | 240005319 | 1.6 | 49.2 | Adjuvant (A) | 2016-04-29 | 2016-05-11 | GEMCITABINE + VINORELBINE | N | N | 240021064 | BEVACIZUMAB |
| 240008712 | 240005320 | 1.84 | 103 | null | null | 2013-12-11 | GemCarbo Days 1+8 | null | null | 240021075 | FLAG |
| 240008713 | 240005321 | 1.77 | 81.3 | Neo-adjuvant (N) | 2015-12-20 | 2015-12-22 | Clofarabine + Cytarabine | N | null | 240021133 | CLADRIBINE + RITUXIMAB |
| 240008714 | 240005321 | 1.71 | 103.7 | Palliative (P) | 2015-04-04 | 2015-04-05 | CLADRIBINE | 2 | N | 240021133 | CYTARABINE |
| 240008715 | 240005322 | null | 54 | null | null | 2018-08-21 | Cisplatin + Topotecan | null | null | 240021159 | RUXOLITINIB |
| 240008716 | 240005323 | 1.66 | 125.6 | Disease modification (D) | 2013-04-14 | 2013-04-15 | Carboplatin + Topotecan | N | N | 240021189 | CHLORAMBUCIL + DEXAMETHASONE + ETOPOSIDE |
| 240008717 | 240005324 | 1.65 | 103 | Curative (C) | 2015-12-24 | 2015-12-24 | TCH (21 day Trastuzumab) Maint | 2 | N | 240021207 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 240008718 | 240010930 | 1.57 | 0 | Curative (C) | 2016-01-22 | 2016-02-13 | ABVD | N | N | 240021222 | CISPLATIN + ETOPOSIDE |
| 240008719 | 240005325 | 1.76 | 69 | Disease modification (D) | 2016-01-08 | 2016-01-08 | Bortezomib + CYCLOPHOSPHAMIDE | 2 | N | 240021224 | FLAG |
| 240008720 | 240005325 | 1.76 | 81.3 | Palliative (P) | null | 2013-12-22 | FCR Oral - Cycle 1 | Y | null | 240021224 | AML18 TRIAL |
| 240008721 | 240005326 | 1.48 | 82 | Curative (C) | 2016-08-22 | 2016-08-22 | DA-EPOCH-R | 99 | null | 240021267 | BEVACIZUMAB + CISPLATIN + PACLITAXEL |